World Journal of Endocrine Surgery

Register      Login

VOLUME 12 , ISSUE 3 ( September-December, 2020 ) > List of Articles

Original Article

Factors Associated with the Efficacy of Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules

Huynh Q Khanh, Nguyen L Vuong, Tran Q Tien

Keywords : Goiter, Radiofrequency ablation, Thyroid nodule, Volume reduction ratio

Citation Information : Khanh HQ, Vuong NL, Tien TQ. Factors Associated with the Efficacy of Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules. World J Endoc Surg 2020; 12 (3):117-121.

DOI: 10.5005/jp-journals-10002-1309

License: CC BY-NC 4.0

Published Online: 02-08-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Background: Minimally thermal treatments, including radiofrequency ablation (RFA), have been widely used for benign thyroid nodules (BTNs). However, factors related to the efficacy are not consistent among studies. Therefore, this study aimed to investigate factors associated with the efficacy and the risk of having multiple RFA sessions in the treatment of BTNs. Materials and methods: We performed a retrospective study of 83 patients with 96 BTNs undergoing RFA from 2018 to 2019. Clinical and ultrasound evaluations were performed before and after RFA 1, 4, 10, and every 6 months afterward. Efficacy outcomes were volume reduction ratio (VRR), symptom and cosmetic scores, and the requirement of multiple RFA sessions. Results: Female was predominant (86%) and the median age was 45 years. Most nodules were solid (64%) with a median volume of 3 mL. Two (2%) minor complications occurred and median time of follow-up was 17 months. The VRR reached to 56.7, 77, 89.4, and 92.8% at 4, 10, 16, and 22 months after the RFA, respectively. The symptom and cosmetic scores also significantly reduced. Multiple RFA sessions were required in 14 nodules (15%). Male had lower VRR of 5.59% than female, while mixed and cystic nodules had higher VRR of 4.88 and 12.7% compared with solid nodule. Larger nodule increased the risk of multiple RFA sessions. Conclusion: Radiofrequency ablation is a safe and effective treatment for BTNs. Gender and solidity associate with VRR, but the large nodule is the risk factor of multiple sessions. More studies are required to reduce the risk of multiple RFA sessions.

  1. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 2010;33(5 Suppl):1–50. DOI: 10.1007/BF03346587.
  2. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351(17):1764–1771. DOI: 10.1056/NEJMcp031436.
  3. Arora N, Scognamiglio T, Zhu B, et al. Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 2008;32(7):1237–1246. DOI: 10.1007/s00268-008-9484-1.
  4. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI: 10.1089/thy.2015.0020.
  5. Bandeira-Echtler E, Bergerhoff K, Richter B. Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev 2014(6):CD004098. DOI: 10.1002/14651858.CD004098.pub2.
  6. Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound 2017;20(1):11–22. DOI: 10.1007/s40477-016-0221-6.
  7. Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia 2019;36(1):1278–1286. DOI: 10.1080/02656736.2019.1700559.
  8. Cho SJ, Baek JH, Chung SR, et al. Long-term results of thermal ablation of benign thyroid nodules: a systematic review and meta-analysis. Endocrinol Metab (Seoul) 2020;35(2):339–350. DOI: 10.3803/EnM.2020.35.2.339.
  9. Kim HJ, Cho SJ, Baek JH, et al. Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis. Eur Radiol 2020;31(2):605–615. DOI: 10.1007/s00330-020-07166-0.
  10. Papini E, Monpeyssen H, Frasoldati A, et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J 2020;9(4):172–185. DOI: 10.1159/000508484.
  11. Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine 2020;67(1):35–43. DOI: 10.1007/s12020-019-02019-3.
  12. Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol 2015;36(7):1321–1325. DOI: 10.3174/ajnr.A4276.
  13. Yue WW, Wang SR, Lu F, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep 2016;6(1):37838. DOI: 10.1038/srep37838.
  14. Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia 2017;33(8):920–930. DOI: 10.1080/02656736.2017.1337936.
  15. Cesareo R, Naciu AM, Iozzino M, et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. Int J Hyperthermia 2018;34(5):617–623. DOI: 10.1080/02656736.2018.1430868.
  16. Deandrea M, Garino F, Alberto M, et al. Radiofrequency ablation for benign thyroid nodules according to different US features: an Italian multicentre prospective study. Eur J Endocrinol 2019;180(1):79–87. DOI: 10.1530/EJE-18-0685.
  17. Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single-center study. Thyroid 2018;28(4):472–480. DOI: 10.1089/thy.2017.0547.
  18. Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol 2018;19(1):167–174. DOI: 10.3348/kjr.2018.19.1.167.
  19. Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine 2019;64(2):316–321. DOI: 10.1007/s12020-018-1829-4.
  20. Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid 2018;28(11):1443–1449. DOI: 10.1089/thy.2018.0180.
  21. Vuong NL, Dinh LQ, Bang HT, et al. Radiofrequency ablation for benign thyroid nodules: 1-year follow-up in 184 patients. World J Surg 2019;43(10):2447–2453. DOI: 10.1007/s00268-019-05044-5.
  22. Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally invasive treatments of the thyroid group. Thyroid 2020;30(12):1759–1770. DOI: 10.1089/thy.2020.0202.
  23. Feroci F, Guagni T, Coppola A, et al. Radiofrequency thermal ablation of benign thyroid nodules: the correlation between ultrasound nodule characteristics and results. Surg Innov 2020;27(4):342–351. DOI: 10.1177/1553350620913134.
  24. Yan L, Luo Y, Xie F, et al. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia 2020;37(1):1139–1148. DOI: 10.1080/02656736.2020.1825835.
  25. Baek JH, Moon WJ, Kim YS, et al. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 2009;33(9):1971–1977. DOI: 10.1007/s00268-009-0130-3.
  26. Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 2010;194(4):1137–1142. DOI: 10.2214/AJR.09.3372.
  27. Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 2014;273(1):241–260. DOI: 10.1148/radiol.14132958.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.